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ABSTRACT 
 
IMPACT OF PHOSPHOINOSITIDES ON REGULATION OF KATP BY ATP AND 
HYDROGEN SULFIDE 
 Tyler Hendon, B.S. in Biochemistry 
A thesis submitted in partial fulfillment of requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2018 
Director: Dr. Diomedes Logothetis, Professor, Department of Physiology and Biophysics 
at Virginia Commonwealth University (Formerly) / Department of Pharmaceutical 
Sciences at Northeastern University (Presently) 
 
 Hydrogen sulfide (H2S) reduces ischemia reperfusion (IR) injury by stimulating 
adenosine triphosphate (ATP) sensitive potassium channels (KATP) [1-5].  Demonstrating 
H2S stimulation is unique to KATP, as other inwardly rectifying potassium (Kir) channels 
demonstrate inhibition or are unaffected [6].  We recently showed that H2S inhibits Kir2 
and Kir3 by decreasing channel sensitivity to phosphatidylinositol 4,5-bisphosphate 
(PI(4,5)P2 or PIP2) [6].  Here, we test the hypothesis that H2S regulation of Kir6.2, a pore-
forming subunit of the KATP channel, is also dependent on PIP2.  Using whole-cell patch-
clamp we show that H2S increases the activity of Kir6.2 channels expressed in HEK-293 
cells.  To study the mechanism, we modulated PIP2 levels by expressing a light-
  
activated phosphatase, or by including high levels of a water-soluble PIP2 analog in the 
patch pipette.  The results suggest that H2S augmentation of Kir6.2 channel activity is 
increased when PIP2 levels are elevated.  
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INTRODUCTION 
 
 Sarcolemmal KATP is comprised of four sulfonylurea receptor (SUR) subunits 
(SUR1, SUR2A, or SUR2B) surrounding four pore-forming Kir6 subunits (Kir6.1 or 
Kir6.2) (Fig. 1).  Different subunit types are predominant depending on tissue type; for 
example, ventricular cardiac myocytes contain predominantly Kir6.2 and SUR2A, and 
pancreatic beta cells contain predominantly Kir6.2 and SUR1 [7, 8].  There are also 
nuclear [9] and mitochondrial forms of KATP [10].  Experiments in pancreatic beta cells 
suggest that nuclear KATP can be comprised of Kir6.2 and SUR1, and the channel is 
suggested to regulate gene transcription in times of metabolic stress [9].  The 
composition of mitochondrial KATP is still debated, and some research suggests that 
they contain none of the Kir6 or SUR subunits found in sarcolemmal and nuclear KATP [7, 
9, 10, 11] - Kir1.2 [7] and Kir1.1b have been suggested as possible pore-forming subunits, 
as well as the possibility that instead of an SUR, they are in complexes with other 
proteins [11].     
 Kir6 is one of seven subfamilies of Kir channels found in humans.  This family of 
channels is marked by a selectivity filter that makes them highly selective to potassium 
ions, as well as an intracellular block from magnesium ions and polyamines that 
promotes the inwardly rectifying characteristic of these channels [12].  These factors 
make these channels an important contributor to the resting membrane potential, 
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limiting the excitability of tissues that express them.  All Kir channels are affected by 
several of the same factors, such as activation by phosphatidylinositol 4,5-bisphosphate 
(PI(4,5)P2 or PIP2) and inhibition by barium ions [13].  Kir6 is unique among Kir channels 
in that this subfamily shows inhibition of channel activity by ATP – a feature that makes 
it important for regulation of metabolically sensitive cells like pancreatic beta cells and 
cardiomyocytes [7]. 
 Structural and functional details of KATP channels have been explored through 
electrophysiology, Molecular Dynamics Simulations (MDS) [6], mutations [4-6], genetic 
analysis of disorders [8, 14, 15], animal models [16-17], biochemical assays [4, 18], and cryo-
electron microscopy (cryo-EM) [19].  These investigations have elucidated a great deal 
about these channels and have facilitated treatments for disorders involving KATP.  For 
example, the sulfonylurea glibenclamide is a widely prescribed medication for type 2 
diabetes that inhibits KATP currents upon binding to the sulfonylurea receptor 1 (SUR1) 
subunit of the KATP channels in pancreatic beta cells.  The resulting membrane 
depolarization opens voltage-dependent calcium channels, increasing intracellular 
calcium levels, thereby stimulating insulin release [14].  
Historically seen as toxic, there are recently uncovered roles for endogenous 
hydrogen sulfide (H2S) in areas such as synaptic activity [20], inflammation [21], insulin 
release [22], and tissue protection against IR injury [1-5], and it is now considered a 
gasotransmitter, like carbon monoxide and nitric oxide.  Endogenous enzymatic 
production from cystathionine γ-lyase, cystathionine-β-synthase, and 3-
mercaptopyruvate sulfurtransferase converts L-cysteine into H2S [23].  Kir6 containing 
KATP channels (Fig. 1) are particularly interesting in the context of Kir modification by 
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H2S, as they demonstrate unique activation [6] and KATP channels are implicated in H2S-
mediated IR injury [1-5].  This potential for H2S to reduce IR injury, by stimulating KATP, 
has the potential to help patients affected by ischemic infarct or during organ 
transplantation.   
While mechanistic details are still being explored, it is thought that H2S acts 
through several KATP-mediated mechanisms to mitigate this damage, including reduction 
of calcium ion influx through hyperpolarization of the membrane, relaxation of smooth 
muscle, suppression of glutamate-induced ROS production by preventing depolarization 
of the mitochondrial membrane [24] by activation of mitochondrial KATP [10].  Mechanisms 
of H2S-mediated protection that do not necessarily involve the activation of KATP have 
also been evidenced, including upregulation of endothelial nitric oxide synthase, Nrf2 
signaling, and mTORC2 phosphorylation of Akt1 [25].  However, several studies indicate 
that an active KATP channel is a critical component of ischemia preconditioning.  For 
example, when it was blocked by glibenclamide [26], or when the predominant ventricular 
cardiac KATP was removed in the creation of Kir6.2-/- knockout mice (which is evidenced 
to not be a critical subunit of mitochondrial KATP [16, 27]), the benefits of ischemia 
preconditioning were “abolished” [16, 26].  Both overexpression of SUR2A and activation 
of KATP by pinacidil or other potassium channel openers, were also shown to mimic the 
effects of ischemia preconditioning [7]. 
H2S modification of Kir channels has been proposed to occur by sulfhydration of 
cysteine residues [6, 23].  The activating effects of H2S on Kir6.1 containing KATP were 
shown to be abolished by a Kir6.1-C43S mutation, providing a strong argument that this 
activation is reliant on the sulfhydration of C43 [5]. Also, a C42R mutation in Kir6.2 has 
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been tied to diabetes [15]. The C43 and C42 cysteine residues, in Kir6.1 and Kir6.2 pore-
forming subunits, respectively, represent a highly conserved cysteine in other Kir 
channels, which is adjacent to the docking site for PIP2 [28], a central Kir channel 
regulator [13], as well as the ATP regulatory site of Kir6.1 and 6.2 [19] (Fig. 1).  
We have studied interactions between Kir channels and PIP2, as well as 
modulatory factors, providing evidence that H2S modification of various Kir channels 
changes the channel dependence on PIP2, using different assays in oocytes and 
Chinese Hamster Ovary (CHO) cells, such as depletion of PIP2 by wortmannin or a 
voltage-sensitive phosphatase, using a short-chain (dioctanoyl), water-soluble analog of 
PIP2, DiC8, and MDS.  This research also showed that effects of NaHS (an H2S donor) 
on other Kir channels changed how they interacted with PIP2 [6].  Also, when expressed 
in oocytes, Kir6.2Δ36 (which lacks the endoplasmic reticulum (ER) retention sequence, 
allowing expression and membrane localization of the functional inwardly-rectifying 
potassium channel that is regulated by ATP and PIP2, without an SUR [29]) shows 
activation by NaHS [6].  The actions of the gasotransmitter carbon monoxide on Kir2.2 
and Kir2.3, which has been shown to act through modification of cysteine residues, like 
H2S [30], has also been linked to modification of channel-PIP2 dependence [31].  Since the 
activity of H2S on Kir channels has been linked to channel/PIP2 interactions by our 
research, including preliminary MDS research that suggests a link to PIP2 affinity [6], 
along with links found in the research of others, and since preliminary experiments with 
KATP and Kir6.2Δ36 show that H2S increased currents in these channels, I tested the 
hypothesis that the H2S enhancement of the predominant ventricular sarcolemmal KATP 
pore-forming subunit, Kir6.2 [27], is dependent on PIP2. 
  5 
 
 
RESULTS 
 
Characteristic Responses of ATP Regulated Kir6.2Δ36 Channels to 3 mM and 0.3 
mM ATP in the Patch Pipette  
In order to examine the impact of H2S on Kir6.2, the pore-forming subunit of the 
KATP channel, the behavior of Kir6.2Δ36 transfected into HEK293 cells, in the absence 
of the H2S donor NaHS, was first examined.  As the activity of Kir6.2 channels is known 
to be sensitive to ATP, different concentrations of ATP were examined for effects on 
Kir6.2Δ36 currents to determine the ATP sensitivity of Kir6.2Δ36 in the environment 
relevant to these experiments (Fig. 2-5).  Whole-cell patch-clamp was employed to 
assay the currents, and different concentrations of ATP were added to the internal 
solution of the patch pipette.  Cells were studied in a solution (here called High-K+) with 
potassium ion (K+) concentrations symmetrical to the internal solution of the patch 
pipette.  High-K+ was perfused following perfusion by a solution with low, quasi-
physiological, concentration of K+ (here called Low-K+), which was used to maintain cell 
health before the assay began. Guided by prior research from the lab responsible for 
the creation of Kir6.2Δ36 [29], I showed that while 3 mM ATP produced significant 
inhibition of High-K+ activated inward currents (Fig. 2 and 6), including 0.3 mM ATP in 
the patch, resulted in a permissive environment in which the High-K+ activated currents 
steadily increased in each of the ~10-minute runs (Fig. 4 and 6). 
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During these experiments Kir6.2Δ36, in my hands, showed the behavior 
anticipated for a Kir channel.  Large currents under the conditions of GΩ level patch-
clamp recording are indicative of successful membrane localization of Kir6.2Δ36 
channels, in the absence of an SUR.  When concentrations of K+ were symmetrical on 
either side of the membrane (i.e. when in High-K+), the inward currents were notably 
larger than the outward currents, as anticipated for an inwardly-rectifying potassium 
channel.  Reversal potentials (EREV) showed variation between runs and occasionally 
differed from values calculated using the Nernst equation.  Deviations from anticipated 
EREV (~ -85 mV in Low-K+ and -1 mV in High-K+) could have been due to a number of 
factors, such as the timing and rate of development of leak affecting the permeability of 
ions and the relevance of using barium-subtracted currents to determine EREV when the 
solution is in High-K+ (such currents being determined by data found during the steady-
state of barium-blocked currents as measured at the end of the ~10-minute 
experiments, and therefore do not necessarily reflect Kir-specific currents at earlier 
times, as the degree of leak is prone to change), as well as variable biological factors 
like the presence and activity of other channels.  As the barium solution is in High-K+, 
Low-K+ currents could not be meaningfully barium-subtracted, meaning they were not 
necessarily Kir-specific, further reducing their utility in accurately determining EREV.  
However, it was consistently demonstrated that the voltage at which the currents were 
equal to zero would continuously right-shift to more positive values, until approximately 
the same point in the time courses where the inflection points mark the end of 
precipitous activation by High-K+ (Fig. 3 and 5).  These points are marked in Figures 2 
and 4 as EREV ≈ 0.  After this point, consistent with the cell remaining in symmetrical K+ 
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conditions, EREV remained relatively stable.  Finally, the inhibition of inward currents 
observed following the start of perfusion of a Ba2+ containing solution is also a hallmark 
of Kir channels, allowing for the determination of currents specific to Kir channels [13] 
(Fig. 2-5).   
To quantify the relative effects of 3 mM and 0.3 mM ATP in the patch pipette, 
first, a percent inhibition from the maximum inward current (IMAX) to the currents 
averaged over the 11 sec period before the start of perfusion by the barium solution was 
calculated for each of the cells studied (by a high-quality whole-cell patch-clamp 
recording).  The latter time point was chosen as perfusion by the barium containing 
solution was not started until a steady-state had been reached, or in the case of runs 
examining the effects of 0.3 mM ATP alone, until sufficient time had passed (i.e. ~10 
minutes) to allow for comparison to other assays utilizing 0.3 mM ATP.  As currents 
being activated by 0.3 mM ATP would continue to activate after the time marking the 
start of barium perfusion until sufficient barium concentrations were reached to inhibit 
the channels, any IMAX values occurring after this time period were excluded.  All 
currents for this and other assays were calculated by averaging the currents from 
approximately 85 to 100 ms into each sweep in order to analyze the inward currents, 
free from any voltage-dependent effects occurring as a result of the immediate transition 
from 0 to -120 mV.  Unless otherwise indicated (e.g. by the phrase “raw currents”), the 
currents analyzed are all also barium-subtracted - meaning that the average of currents 
over 11 sec during steady-state inhibition by the barium solution was measured for each 
run and subtracted from the raw currents in that run, in order to limit the analysis to Kir-
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specific currents.  Currents shown for representative time courses and voltage-ramp 
sweeps are raw currents. 
The resulting average of the 3 mM ATP percent inhibitions of the Kir6.2Δ36 
channel currents was 67% +/- 12% (SEM), n = 5, p = 0.003.  Also, in accordance to the 
findings of Tucker et al. [29], we found that in my hands 0.3 mM ATP in the patch pipette 
created a permissive environment for High-K+ activated currents, which gradually 
increased over each of the ~10-minute experiments analyzed.  Correspondingly, the 
average percent inhibition from IMAX with 0.3 mM ATP, calculated as for 3 mM ATP, was 
found to not be statistically different than 0% (9.6% +/- 4.4% (SEM), n = 6, p = 0.084).  
As anticipated, the average percent inhibition from IMAX for 3 mM was significantly 
greater than that calculated for 0.3 mM ATP (p = 0.003) (Fig. 6).  As one would 
anticipate from the steady activation by 0.3 mM ATP (Fig. 4), these times for IMAX would 
occur shortly before the analyzed period before barium inhibition, often corresponding to 
a transient spike in currents from mechanical and biological noise (an average of 25 sec 
+/- 5 sec (SEM) before), while IMAX from 3 mM ATP runs of approximately the same 
length (~10 min before perfusion of the barium solution) would take place an average of 
375 sec +/- 64 sec (SEM) before, and would correspond to a clear inflection point in the 
time courses for inward currents, which we interpret as a reflection of sufficient 
exogenous ATP diffusing into the cell, from the pipette, to inhibit Kir6.2Δ36 (Fig. 2).    
These results demonstrate that the behavior of Kir6.2Δ36 shown by Tucker et al. 
[29], could be consistently replicated in my hands.  With this empirical confirmation of the 
utility of the experimental conditions with 0.3 mM ATP in the patch pipette, it was 
decided to proceed with experiments attempting to alter Kir6.2Δ36 currents by 
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manipulating PIP2 levels in the cell.  First, we aimed to inhibit currents by the depletion 
of PIP2 through a light-sensitive phosphatase system pioneered by Hille and De Camilli 
et al [32]. 
 
5-ptase + CIBN-CAAX Light-Stimulation Showing Large Inhibition of Kir2.3 
Currents 
The light-activated phosphatase system used is comprised of two fusion proteins: 
CRY2-5-ptaseOCRL contains the photolyase domain of cyrptochrome 2 (CRY2) and the 
inositol 5-phosphatase domain of the Lowe oculocerebrorenal syndrome protein 
(OCRL), while CIBN-CAAX contains the CRY2 binding domain (CIBN) and a C-terminal 
CAAX box for plasma membrane targeting.  When CRY2-5-ptaseOCRL and CIBN-CAAX 
fusion proteins are co-expressed and exposed to light between 458-488 nm, the 5-ptase 
is localized to the plasma membrane, where it dephosphorylates PIP2.  The utility of this 
system to study the PIP2 dependence of ion channel activity was demonstrated by the 
Hille and De Camilli labs. Within seconds of light-stimulation, they observed the 
inhibition of KCNQ2/3 channel currents corresponding to the rapid dephosphorylation of 
the 5-phosphates of PIP2, as well as PI(3,4,5)P3 [32].  
I used Kir2.3 as a positive control to demonstrate that the light-sensitive 
phosphatase system worked in my hands, since unpublished data in the lab by Plant et 
al. had previously shown it to inhibit this channel in whole-cell patch-clamp.  Also, Kir2.3 
is activated by PIP2 to a similar degree as Kir6.2 [33], and Kir6.2 has been shown to 
possess a similar affinity for PIP2 as Kir6.2Δ36 [18].   
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In my hands, the activation of the phosphatase significantly inhibited Kir2.3 
currents by an average of 79% +/- 4.3% (SEM), n = 6, p < 0.001, as calculated by 
comparing the average of currents over the 11 sec before exposing the cells to 460 nm 
light, to the 11 sec average before the start of perfusion by the barium containing 
solution (Fig. 9).  The inhibition began within a few seconds, as shown in the 
representative time course in Figure 7, consistent with previous research [32].  Once the 
inhibition reached steady-state, allowing for the percent change in currents to be 
calculated, the perfusion of the barium containing solution would begin. 
 
5-ptase + CIBN-CAAX Light-Stimulation Shows No Discernible Inhibition of 
Kir6.2Δ36 Currents 
After approximately thirty attempts to adjust conditions, and to maximize 
likelihood that vectors were successfully transfected into the cell being examined, it 
became clear that activation of the light-sensitive phosphatase resulted in no 
observable change in Kir6.2Δ36 currents during the same time course observed in 
experiments with convincing Kir2.3 inhibition (Fig. 7-9).  From these attempts, 13 were 
found to be of high enough quality to include in analysis.  The analysis of these runs, 
performed as described for Kir2.3, showed that the currents did not significantly change 
from the time before the point of light-stimulation to the time before perfusion by the 
barium solution (average percent change = +13% +/- 9.4% (SEM), n = 13, p = 0.189).  
Since this is significantly different from the average percent change with Kir2.3 under 
similar conditions (p < 0.001) (Fig. 9), and the channels were anticipated to behave 
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similarly due to their similar affinity for PIP2, we felt that further analysis of this disparity 
was warranted. 
 
Effects of 0.3 mM ATP in the Patch Pipette on Kir6.2Δ36 Current, with and without 
5-ptase + CIBN-CAAX 
 To further analyze the unanticipated behavior of the light-sensitive phosphatase 
system on Kir6.2Δ36, a comparison was made between when the system was present 
and when it wasn’t (Fig. 10), using the same 0.3 mM ATP data generated to compare 
the effects of 0.3 and 3 mM ATP, in the patch pipette, on the channel (Fig. 4-6).  To 
further illustrate this unanticipated behavior, a figure was included to show the averages 
of raw currents over the 11 sec before light-stimulation, and the 11 sec before the 
perfusion by the barium solution, for the run made in the presence of the 5-ptase 
system (Fig. 10A).  For comparison, the same presentation is made for data generated 
without the system present, and since no times of light-stimulation correspond to these 
data, and the length of between the relevant time points is approximately equal whether 
or not the system is present, the average time of light-stimulation for the Kir6.2Δ36 data 
for which the system was present (t = 146 sec) was used in place of the time of light-
stimulation for the data in which it was not (Fig 10B).   
Determination of the average of percent changes from runs with the 5-ptase 
system was performed as described for Figure 9, which also shows the result of +13% 
+/- 9.4% (SEM), n = 13.  For data in which the system was not present, this analysis 
was performed by using the t = 146 sec average in place of the starting time of light-
stimulation, and the average of percent changes from the average of currents over 11 
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sec before that point to the average of currents over 11 sec before the start of perfusion 
by the barium solution was found to be +190% +/- 59% (SEM), n = 6, p = 0.011.  This 
anticipated activation by the permissive environment of 0.3 mM ATP was found to be 
significantly muted when in the presence of the light-stimulated phosphatase system (p-
value = 0.001) (Fig. 10C), even though no observable rapid change was triggered by 
light-stimulation taking place (Fig. 8).  The potential mechanisms of this long-term 
impact are detailed in the “Discussion” section.  However, as the effects of the system 
were not the rapid inhibition of currents by the depletion of PIP2 that was anticipated, a 
more direct manipulation of PIP2 levels was employed by using a water-soluble analog 
of PIP2, DiC8, in order to examine the resulting impact of increasing levels of PIP2 on 
Kir6.2Δ36 activation by NaHS.        
 
Average Percent Change of Kir6.2Δ36 Currents by Perfusion of 3 mM NaHS with 
and without 0.2 mM DiC8 in the Patch Pipette  
A patch pipette concentration of DiC8 in whole-cell patch-clamp experiments of 
0.2 mM DiC8 has been shown previously by our lab to be both viable and near the 
upper end of what has been shown to facilitate assayable differences in currents [34].  
Consequently, it was decided to use this concentration to look for changes in the degree 
of activation of Kir6.2Δ36 currents by NaHS. 
Our previous experiments in oocytes showing inhibition of Kir3.2* currents and 
activation of Kir6.2Δ36 currents by incubating the oocytes in 2 mM NaHS solution for 
over 100 minutes, demonstrated significantly diminished regulation with shorter 
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incubation periods [6].  In contrast, I was able to see activation of Kir6.2Δ36 currents 
from 3 mM NaHS in HEK293 cells begin within a few seconds and reach steady-state 
within ~10 minutes (Fig. 11 and 12).  The data were analyzed in the same manner used 
to determine the average percent change from the light-stimulation of the phosphatase 
system, except that instead of the time of light-stimulation the start of the perfusion by 
the NaHS solution was used.  Resulting data was used to compare the average percent 
activation of Kir6.2Δ36 currents by NaHS for when 0.2 mM DiC8 was present in the 
patch pipette to when it was not. 
The average percent activation by NaHS when DiC8 was not present was 370% 
+/- 120% (SEM), n = 6, p = 0.013.  With 0.2 mM DiC8 in the patch pipette the average 
percent activation was 530% +/- 120% (SEM), n = 6, p = 0.003.  While the percent 
activation in the presence of 0.2 mM DiC8 does not indicate significance within the 
constraints of a 95% confidence interval (p = 0.087), the data do seem to indicate a 
trend that might reach significance with further experimentation. 
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DISCUSSION 
 
In examining the ATP sensitivity of Kir6.2Δ36, I found that 0.3 mM ATP in the 
patch pipette allowed for stable High-K+ activated currents, suitable for analysis by 
further manipulation.  Next, as attempts to utilize a light-sensitive phosphatase system 
under these conditions did not yield a demonstrable, rapid inhibition of currents that 
could be tied to PIP2 reduction, experiments involving the addition of DiC8 to the patch 
pipette were carried out.  Finally, under the conditions suggested by these experiments, 
the hypothesis that activation of Kir6.2 by H2S is dependent on PIP2 was tested.  I found 
that in experimental conditions with additional PIP2 (in the form of DiC8) introduced into 
the cells, the effects of H2S donor NaHS was increased, showing a nearly statistically 
significant trend (p = 0.087).  It is possible that a larger set of experiments would show 
statistical significance.  Although limited in scope, these findings may help widen the 
body of knowledge associated with KATP regulation, and hopefully contribute towards the 
development of treatments less deleterious than H2S ischemia preconditioning.  By 
providing information about Kir channel/PIP2 interactions, and how they can be 
manipulated, it may also help to elucidate other Kir related medical conditions, 
particularly those associated with Kir6.2, such as diabetes. 
Initial whole-cell patch-clamp experiments focused on determining the 
applicability, in my hands, of research performed by Tucker et al. [29] (the first lab to 
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report using Kir6.2Δ36).  Specifically, to see if their findings that, while 3 mM ATP in the 
patch-pipette would be inhibitory, 0.3 mM ATP would allow for Kir6.2Δ36 currents large 
enough to allow for assaying modulation by other channel regulators.  I found their 
research to be reproducible, and that activation by including 0.3 mM ATP in the patch 
pipette provided a stable environment in which I could perform my planned experiments.  
While using 0 mM ATP could be considered for activating an ATP-inhibited channel like 
this one, these conditions were rejected to allow for the general health of the cell over a 
several minute whole-cell patch-clamp experiment, already involving unfavorable 
conditions like higher than physiological concentrations of K+, and to allow for the 
endogenous synthesis of PIP2 and other relevant phosphoinositides. 
When it was discovered that the light-sensitive phosphatase system, which 
worked as anticipated in my hands and those of others for Kir2.3, was not 
demonstrating discernible inhibition of Kir6.2Δ36 currents within seconds of light-
stimulation, but did appear to have a significant long-term impact, an investigation was 
begun into previous research for reasons why that may be the case.  First, I found that 
our own lab’s investigations of how phosphoinositides effect Kir channels had shown 
that Kir6.2 containing KATP and Kir6.2Δ36 channels were activated by a greater range of 
phosphoinositides than Kir2.3, as well as other Kir channels investigated [35].  However, 
the study did not explicitly test the effects of PI(4)P, which is generated 1:1 by the 
depletion of PI(4,5)P2 by the 5-phosphatase I employed here.  While the levels of other 
phosphoinositides would also be affected, namely depletion of PI(3,4,5)P3 into 
PI(3,4)P2, the impact of these changes on Kir6.2Δ36 currents are likely to be negligible, 
even though Kir6.2Δ36 shows activation from each comparable to PI(4,5)P2 [35], 
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because i) they are present in HEK-293 cells at relatively low levels [36], and ii) the 
depletion of PI(3,4,5)P3 creates the PI(3,4)P2 1:1, and their degree of activation of the 
Kir6.2Δ36 is approximately equal [35]. 
Further investigation into past research revealed that when a voltage-sensitive 5-
phosphatase was used to deplete PI(4,5)P2, while causing inhibition of Kir2.1, Kv7.2, 
and Kv7.3, it had virtually no effect on KATP comprised of Kir6.2 and SUR1.  
Hypothesizing that the PI(4)P created by this phosphatase was activating KATP to a 
similar degree as PI(4,5)P2, the authors then used direct application, to excised patches 
after run-down of endogenous phosphoinositides, of either PI(4,5)P2 or PI(4)P to show 
that, while only PI(4,5)P2 activated Kir2.1, both PI(4,5)P2 and PI(4)P “similarly activated 
Kir6.2/SUR1.”  As their experiments generally took place in under 200 sec, long-term 
effects like those I observed were not analyzable [37]. 
Furthermore, to explore possible relevant differences in affinity of 
phosphoinositides in Kir6.2 containing KATP channels versus Kir6.2Δ36, Wang and 
colleagues used a dot-blot assay with Kir6.2Δ35 against several phosphoinositides, 
evidencing a similar binding efficiency for PI(4,5)P2 and PI(4)P [18].  
Convinced by my own empirical data and support of the cited literature, we feel it 
is likely that the light-sensitive phosphatase system did not produce the anticipated 
inhibition of currents within seconds of light-stimulation because PI(4)P is approximately 
as effective as PI(4,5)P2 in activating Kir6.2Δ36 channels, and was being generated at 
the same rate of the depletion of PI(4,5)P2.  The significant difference found over longer 
time periods after light-stimulation of the phosphatase system, as compared to 0.3 mM 
ATP alone, could be due to multiple factors.  Possibilities include i) the potential of 
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PI(4)P to have a lower affinity than PIP2 for Kir6.2Δ36 (although, if the hypothesis is 
correct that the depletion of PIP2 did not have any observable, rapid impact on currents 
because of its replacement with PI(4)P, then we would also hypothesize that any effects 
on currents due to PI(4)P/channel affinity would be as rapidly apparent as the effect of 
the depletion of PIP2 on other channels), ii) unrelated effects of PIP2 depletion or PI(4)P 
generation on cellular metabolism, and iii) the effects of PI(4)P, as compared to PIP2, on 
the proximate ATP binding pocket.  In support of the latter hypothesis, 
phosphoinositides have been evidenced to directly impact the affinity of ATP for 
Kir6.2Δ35 [18], and as the effect currents by the light-stimulation of the phosphatase 
were slow, the correlation to the rate of change of currents caused by the dilution of 
cellular ATP from having 0.3 mM ATP in the patch pipette may indicate a causal 
relationship.   
While it could still be informative to test for the PIP2 dependent effects of H2S 
activation of KATP currents by investigating for potential differential dependence on 
PI(4,5)P2 versus PI(4)P, given the limited scope of this Master’s thesis work, we decided 
to investigate this potential PIP2 dependence through more direct means - by comparing 
the effects of the H2S donor NaHS between the endogenous levels of PIP2 and 
increased PIP2 levels, through the inclusion of its water-soluble analog (DiC8), in the 
patch pipette. 
This method allowed for the investigation of the central hypothesis, that H2S 
activation of Kir6.2 currents is dependent on PIP2.  To this end, comparisons were 
made between endogenous levels of PIP2 and conditions in which additional short-chain 
PIP2 was added through the patch pipette, with the expectation that endogenous PIP2 
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would predominantly remain in the lipid membrane, and the amount lost during 
equilibrium with the internal solution of the patch pipette would remain approximately 
consistent between these conditions.  It was found that, when in the presence of 
additional short-chain PIP2, the average percent activation of currents by NaHS was 
higher (530% +/- 120% (SEM), n = 6, p = 0.013) than without DiC8 (340% +/- 120% 
(SEM), n = 6, p = 0.003).  Falling between a 90-95% confidence interval (p = 0.087), the 
statistical significance of this difference in average percent activation by NaHS suggests 
that increased levels of PIP2 would facilitate H2S activation of Kir6.2.  The statistical 
analysis of this, and all other statistical analysis in this paper, is limited by the number of 
repetitions of each experiment.  As such, it is possible that additional repetition would 
increase the statistical significance to above the 95% confidence interval.   
The goal of this research is to further the understanding of KATP channels and the 
interaction of regulatory factors, particularly ATP, PIP2, and H2S, in order to facilitate the 
development of medical therapies.  Since these findings are limited to Kir6.2Δ36, 
instead of the complete KATP channel, the medical applicability of these findings may be 
limited by the absence of the regulatory SUR subunits, which have also been 
demonstrated to be directly modified by H2S [4].  However, as I demonstrate that my 
experimental conditions still involve a functional inwardly-rectifying potassium channel 
that demonstrates regulation by ATP, PIP2, and H2S, the information gained may still be 
quite valuable.   
As H2S is known to affect many important biological processes [1-6, 20-23, 25, 30], its 
medical application for targeted effects, such as activating sarcolemmal KATP in 
ventricular cardiac myocytes to reduce IR injury, is bound to have considerable off-
  19 
target effects.  Indeed, it has been shown that H2S preconditioning, while 
cardioprotective, actually furthers neuronal damage during IR.  The exact cause is still 
being investigated, but it has been shown that H2S has a depolarizing effect on 
neuronal tissue, instead of the hyperpolarizing effect it has on cardiac tissue [38].  This 
may be due to the fact that it inhibits many Kir channels, and this effect could 
overwhelm the effects of neuronal Kir6 channels being activated [6] - investigations into 
the relative expression patterns and corresponding contributions from inhibition or 
activation of Kir channels in specific neurons could help our understanding in this 
matter.  The more we understand about these concepts, the better chance we have for 
developing a more focused therapy, such as a Kir6.2 or cardiac tissue specific 
treatment that quickly increases Kir channel-PIP2 interactions.   
In conclusion, my patch-clamp studies using Kir6.2Δ36 are consistent with our 
previous work on Kir2 and Kir3 channels in that the H2S effects on these channels 
suggest dependence on phosphoinositides.  H2S modulation under high PIP2 level 
conditions suggest an augmented activation of Kir6.2Δ36 currents.  Presumably the 
availability of increased PIP2 in the inner leaflet of the plasma membrane allowed for 
enhanced interactions by H2S post-translational modifications. 
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MATERIALS AND METHODS 
 
 Materials – Dioctanoyl PIP2 (DiC8) was purchased from Echelon (Salt Lake, UT). 
It was dissolved in water in 6 mM stock solution aliquots and stored at -80°C.  On the 
day of the experiment it was diluted in the intracellular solution to a concentration of 0.2 
mM.  NaHS was purchased from Strem (Newburyport, MA) and on the day of 
experiments it was dissolved into the High-K+ solution to a concentration of 3 mM. 
 Molecular Biology – Kir2.3 was handled in pcDNA and eGFP was handled in 
peGFP-C1.  Kir6.2Δ36 was subcloned from pGEM-HE (as used by Ha et al. [6]) to 
pXoom, a plasmid with a CMV promoter for expression in mammalian cells.  CRY2-5-
ptaseOCRL and CIBN-CAAX were gifted from the De Camilli lab in mammalian 
expression vectors under the control of CMV promoters [32].  
 Electrophysiology – Whole-cell currents were measured by conventional patch-
clamp with an Axopatch 200B amplifier (Molecular Devices) controlled via a USB-
interface (National Instruments) using WinWCP software (University of Strathclyde).  In 
all cases, currents were acquired through a lowpass Bessel filter at 2 kHz and were 
digitized at 10 kHz.  Patch pipettes were fabricated using a Narishige PC-10 puller and 
had a resistance of around 6 MΩ when filled with an intracellular solution comprising: 
140 mM KCl, 2 mM MgCl2, 1 mM EGTA, 0.3 or 3 mM Na2ATP, 0.1 mM Na2GTP, and 5 
mM HEPES; pH = 7.2.  Cells for study were selected based on eGFP expression using 
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an epifluorescence microscope (Nikon).  To study Kir channel currents, cells were held 
at 0 mV, and currents were assessed by ramps from -120 to +80 mV (as shown and 
described in Figure 3).  Cells were perfused via a multi-channel gravity-driven perfusion 
manifold, with the Low-K+ solution, then quickly transitioning to the High-K+ solution (at 
~10 s).  The barium solution was perfused at the end of each run to determine the 
magnitude of the barium-sensitive currents.  The High-K+ solution comprised: 5 mM 
NaCl, 135 mM KCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 8 mM Glucose, and 10 mM HEPES; 
pH = 7.4.  The Low-K+ solution comprised: 135 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 1.5 
mM CaCl2, 8 mM Glucose, and 10 mM HEPES; pH = 7.4.  Barium was used at 3 mM 
BaCl2 in the High-K+ solution.  Barium sensitive currents were defined as the difference 
between the steady-state currents while cells were perfused by High-K+ and barium-
containing solutions. 
 Because H2S can interact with the silver chloride that forms the ground 
electrodes used, patch-clamp studies were performed using a salt bridge between the 
recording chamber and the ground wire.  The salt bridge was formed by 1 M KCl 
solution soaked into 2% agarose and was housed in a 3 cm length of P160 tubing 
(Warner Instruments). 
Currents were primarily analyzed in the range of 85 – 100 ms in each sweep to 
investigate inward currents.  Light-stimulation was achieved using a 460 nm LED 
(Luminus PT-54-TE) that was focused on the cells through the objective lens of an 
inverted microscope (Nikon).  Data acquisition and analysis was carried out using 
WinWCP V5.2.9, ClampFit 10.7 (Molecular Devices), and Microsoft Excel.  
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 Culture of HEK-293-E Cells – Cells were maintained in DMEM supplemented 
with 10% FBS and 1% Penicillin Streptomycin (Hyclone). Plasmids were transfected 
into cells with Lipofectamine 2000 (ThermoFisher) or EcoTransfect (OzBiosciences) 
according to the manufacturer’s instructions, in Opti-MEM (ThermoFisher).  Cells were 
cultured in Corning 100 mm x 20 mm cell culture treated dishes until approximately 80% 
confluence.  They were then trypsinized with 1 ml of 0.05% Trypsin (Hyclone), left to 
detach for ~3 minutes and diluted with 14 ml of the supplemented DMEM.  Four glass 
cover-slips were coated with trypsinized cells in a BioLite 35 mm tissue culture dish 
(ThermoFisher) and allowed to attach over 10 minutes before the addition of 2 ml of 
supplemented DMEM.  The next day, transfection was performed with 1 µg of Kir 
channel vector, 0.75 µg each of DNA for CRY2-5-ptaseOCRL and CIBN-CAAX vectors, 
and 0.25 µg of eGFP vector.  Cells were studied 24 hours later with eGFP fluorescence 
used as a marker of protein expression. 
Data Analysis and Statistics – All data are reported as mean +/- Standard Error 
of the Mean (SEM); ‘n’ represents the number of cells assayed and included in the 
analysis for each condition.  Average percent changes were calculated as described in 
the “Results” section and corresponding figure legends. The statistical significance of 
the data were assessed using the “Single Sample t-Test” and “Mann-Whitney Test” 
online calculators provided by Vassar College.  Data were analyzed using one or two-
tailed tests, as stated in the corresponding figure legends, based on the hypothesis 
under investigation.  Data were analyzed as one-tailed if previous evidence suggested a 
direction of change, positive or negative – otherwise the analysis was two-tailed. 
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Figure 1 
KATP Channel Subunits and Select Regulatory Factors: (Top left) schematic of one 
Kir6 and one SUR subunit of the KATP octamer, localized across a cellular membrane 
with “Out” and “In” used to mark extracellular and intracellular regions, respectively.  For 
Kir6, the N-terminus, C-terminus, M1 and M2 membrane domains, and the P-loop gate 
are shown.  In the Kir6.2Δ36 mutant, the last 36 amino acids of the C-terminus have 
been deleted.  For SUR, the three transmembrane domains, TMD0, TMD1, and TMD2 
are marked, along with the 2 nucleotide-binding folds, NBF1 and NBF2, as well as the 
N-terminus and C-terminus.  (Top right) Shows a schematic of the basic organization of 
the octamer, with the four Kir6 pore-forming subunits surrounded by the four SUR 
subunits.  (Bottom) Cutaway of the KATP octamer, showing half the channel, localized in 
a cellular membrane.  Binding sites for ATP, ADP, MgATP, MgADP, and PIP2 are 
shown, as well as the black dashed line in the center showing the permeation path of 
K+. Adapted from Nichols, C. G., Singh, G. K., & Grange, D. K. (2013). KATP Channels 
and Cardiovascular Disease: Suddenly a Syndrome. Circulation Research, 112(7), 
1059–1072. https://doi.org/10.1161/CIRCRESAHA.112.300514. 
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Figure 2 
High ATP in the Patch Pipette Inhibits Kir6.2Δ36 Currents: Representative time 
course of whole-cell patch-clamp currents with HEK-293 cells transfected with 
Kir6.2Δ36 and recorded with 3 mM ATP in the patch pipette.  Perfusion by the High-K+ 
solution began at time = 10 sec and perfusion by the barium solution began at 700 sec.  
Colored arrows mark points corresponding to representative sweeps shown in Figure 3, 
with trace colors matching arrow colors. The inset legend is also color-matched to 
corresponding arrows, where blue is t = 2 sec, during perfusion by the Low-K+ solution; 
orange is t = 43 sec, during activation by High-K+ solution; yellow is t = 146 sec where 
IMAX occurs as well as the start of EREV ≈ 0; light-red is t = 218 sec, during ATP 
inhibition; dark-red is t = 454 sec, during ATP inhibition steady-state; and green is t = 
754 sec, during perfusion by the barium solution.  Pipette resistance = 7.1-7.3 MΩ.  
Series Resistance = 18.5 MΩ.  Whole Cell Capacitance = 3.4 pF.  Recording 
Resistance ≈ 1 GΩ. 
 
 
 
 
 
 
-1200
-1000
-800
-600
-400
-200
0
0 100 200 300 400 500 600 700 800
C
u
rr
e
n
t 
(p
A
)
Time (sec)
Source of 
Representative Sweeps
1) T = 2 sec (5 mM K+)
2) T = 43 sec 
(Activation of 
current in 135 mM
K+)
3) T = 146 sec (Ipeak, 
and Apparent Erev ≈ 
0 mV)
4) T = 218 sec (During 
ATP Inhibition)
5) T = 454 sec (ATP 
Inhibition, steady 
state)
6) T = 754 sec (3 mM
Ba2+ block)
1
2
3
4
5
6
Figure 2
  30 
 
 
Figure 3 
Representative Voltage-Ramp Current Sweeps from Time Course for Kir6.2Δ36 
Inhibition by 3 mM ATP in the Patch Pipette: (Top) Color coded sweeps 
corresponding to colors and times from Figure 2, generated by the voltage-ramp 
protocol (bottom).  The behavior of the channel with 3 mM ATP in the patch pipette first 
shows activation from increasing external K+ concentration in the transition from the 
Low-K+ to High-K+ solutions, then inhibition after a sufficient concentration of ATP 
diffuses from the patch pipette into the cell.  In this example, currents were inhibited to 
the point where the perfusion of the barium solution contributes negligibly to further 
inhibition. (Bottom) Voltage-ramp protocol – each sweep is 1 sec, with times not shown 
being at the holding potential of 0 mV.  From left to right, t = 0 – 50 ms are at 0 mV; t = 
50 – 100 ms of -120 mV; t = 100 – 300 ms is a linear increase in voltage from -120 mV 
to +80 mV; and t = 350 – 400 ms holds at 0 mV. 
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Figure 4 
0.3 mM ATP in the Patch Pipette Permits Rather than Inhibits Kir6.2Δ36 Currents: 
Representative time course of whole-cell patch-clamp currents with HEK-293 cells 
transfected with Kir6.2Δ36, recorded with 0.3 mM ATP in the patch pipette.  Perfusion 
by the High-K+ solution began at t = 19 sec and perfusion by the barium solution began 
at 790 sec.  Colored arrows mark points from which representative sweeps are taken 
and shown Figure 5, with trace colors matching arrow colors.  The inset legend is also 
color-matched to corresponding arrows, where blue is t = 2 sec, during perfusion by the 
Low-K+ solution; orange is t = 50 sec, during activation in the High-K+ solution; grey is t 
= 71 sec where EREV ≈ 0; yellow is t = 815 sec, at the point of IMAX;  and green is t = 887 
sec, during perfusion by the barium solution, while in steady-state inhibition.  Pipette 
resistance = 5.0-5.2 MΩ.  Series Resistance = 12.5 MΩ.  Whole Cell Capacitance = 
32.9 pF.  Recording Resistance ≈ 0.5 GΩ.  
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Figure 5 
Representative Voltage-Ramp Current Sweeps from Time Course for Kir6.2Δ36 
with 0.3 mM ATP in the Patch Pipette: (Top) Color coded sweeps corresponding to 
colors and times from Figure 4, generated by the voltage-ramp protocol (bottom).  The 
behavior of the channel with 0.3 mM ATP goes as anticipated, showing activation by 
increasing K+ concentration in the transition from the Low-K+ to High-K+ solutions, then 
maintains an environment permissive to the activated currents as ATP diffuses from the 
pipette into the cell, then the currents are inhibited by perfusion of the barium solution. 
(Bottom) Voltage-ramp protocol – each sweep is 1 sec, with times not shown being at 
the holding potential of 0 mV.  From left to right, t = 0 – 50 ms are at 0 mV; t = 50 – 100 
ms of -120 mV; t = 100 – 300 ms is a linear increase in voltage from -120 mV to +80 
mV; and t = 350 – 400 ms holds at 0 mV. 
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Figure 6 
Effects of 0.3 mM Compared to 3 mM ATP on Kir6.2Δ36 Currents:  Whole-cell 
patch-clamp inward currents from HEK293 cells transfected with Kir6.2Δ36, generated 
in the presence of either 0.3 mM or 3 mM ATP in the patch pipette (representative 
traces shown in Figures 2-4), were collected and analyzed.  From each run, the percent 
inhibition from the maximum inward current (IMAX) to the average of currents generated 
from the 11 sec before the start of perfusion by the barium solution.  The averages of 
these percent inhibitions are presented here.  The average percent inhibition for 0.3 mM 
ATP was 9.6% +/- 4.4% (SEM), n = 6.  A 1-sample t-test was performed to test H0: μ = 0 
against HA: μ ≠ 0, and found that this average was not statistically different from 0%, p-
value = 0.084.  The average percent inhibition for 3 mM ATP was 67% +/- 12% (SEM), 
n = 5.  A 1-sample t-test was performed to test H0: μ = 0 against HA: μ > 0, and found 
the average inhibition to be statistically greater than 0%, p-value = 0.003.  A one-tailed 
Mann-Whitney U test analysis was performed to test the H0 that the two concentrations 
did not result in statistically distinct inhibitions from IMAX, against the HA that 3 mM ATP 
results in greater inhibitions from IMAX than 0.3 mM ATP, and found that 3 mM ATP 
results in significantly greater inhibitions, p-value = 0.003.  * indicates p<0.05.  
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Figure 7 
5-ptase + CIBN-CAAX Light-Stimulation Showing Large Inhibition of Kir2.3 
Currents:  Representative time course of whole-cell patch-clamp currents with HEK-
293 cells transfected with Kir2.3, the 5-ptase, and CIBN-CAAX, with 0.3 mM ATP in the 
patch pipette.  Perfusion by the High-K+ solution began at t = 10 sec; light-stimulation of 
the phosphatase system began at t = 150 sec (marked by vertical blue line); and 
inhibition from the resulting depletion of PIP2 proceeds until reaching a steady-state, at 
which point the barium solution perfusion was started (t = 250 sec).  The voltage-ramp 
protocol used was identical to the one shown in Figures 3 and 5. Pipette resistance = 
6.1-6.3 MΩ.  Series Resistance = 19.3 MΩ.  Whole Cell Capacitance = 13.9 pF.  
Recording Resistance ≈ 1 GΩ. 
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Figure 8 
5-ptase + CIBN-CAAX Light-Stimulation Shows No Observable Rapid Inhibition of 
Kir6.2Δ36 Currents: Representative time course of whole-cell patch-clamp currents 
with HEK-293 cells transfected with Kir6.2Δ36, the 5-ptase, and CIBN-CAAX, with 0.3 
mM ATP in the patch pipette.  Perfusion by the High-K+ solution began at t = 10 sec; 
light-stimulation began at t = 205 sec (marked by vertical blue line); no observable rapid 
change in the behavior of the currents occurred after light-stimulation, but signs of long-
term inhibition were apparent; and perfusion by the barium solution began at t = 655 
sec.  The voltage-ramp protocol used was identical to the one shown in Figures 3 and 5. 
Pipette resistance = 7.6-7.8 MΩ.  Series Resistance = 15.1 MΩ.  Whole Cell 
Capacitance = 20.8 pF.  Recording Resistance ≈ 1 GΩ. 
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Figure 9 
Average Percent Change in Currents by 5-ptase + CIBN-CAAX Light-Stimulation 
for Kir6.2Δ36 Compared to Kir2.3:  Whole-cell patch-clamp inward currents 
comparing the average of currents over 11 sec before the light-stimulation to the 
average of currents over 11 sec before beginning the barium solution perfusion, which 
corresponds to the steady-state after changes in currents, were collected and analyzed 
to find a percent change for each run.  These percent changes were averaged and are 
shown here.  For Kir6.2Δ36, the current showed an average percent change of +13% 
+/- 9.4% (SEM), n = 13.  A 1-sample t-test was performed to test H0: μ = 0 against HA: μ 
≠ 0, and found that this average was not statistically different from 0%, p-value = 0.189.  
For Kir2.3, the currents showed an average percent change of -79% +/- 4.3% (SEM), n 
= 6.  A 1-sample t-test was performed to test H0: μ = 0 against HA: μ > 0, and found that 
this average inhibition was statistically greater than 0%, p-value < 0.001.  A two-tailed 
Mann-Whitney U test analysis was performed to test the H0 that the light-stimulated 5-
ptase system had a statistically similar long-term effect on both channels, against the HA 
that, although similarly activated by PIP2, the channels had statistically distinct 
responses, giving a p-value < 0.001.  * indicates p<0.05. 
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Figure 10 
Effects of 0.3 mM ATP in the Patch Pipette on Kir6.2Δ36 Currents, with and 
without 5-ptase + CIBN-CAAX:  In order to determine if the light-stimulation of the 5-
ptase system had a significant long-term impact on Kir6.2Δ36 currents, data from cells 
transfected with the channel, and with 0.3 mM ATP in the patch pipette, were analyzed 
to compare between those co-transfected with the 5-tase system and those without. A) 
Colored lines connect data points from the same run, representing the average of 
currents over 11 sec before light-stimulation to the average of currents over the 11 sec 
before perfusion by the barium solution for co-transfected cells.  B) Since no light-
stimulation was attempted in runs without the 5-ptase present, the average start of light-
stimulation from the co-transfected data set (t = 146 sec) was used to analyze data 
generated without, and otherwise the analysis was performed as in Figure 10A.  C) The 
average of the percent changes found for each run with the 5-ptase system, and its 
statistical test, is the same as presented in Figure 9 (+13% +/- 9.4% (SEM), n = 13, p = 
0.189).  Without the system, the average change was +190% +/- 59% (SEM), n = 6.  A 
1-sample t-test was performed to test H0: μ = 0 against HA: μ > 0, and found that this 
average was statistically greater than 0%, p-value = 0.011.  A two-tailed Mann-Whitney 
U test analysis was performed to test the H0 that the light-stimulation of the 
phosphatase system, in the presence of 0.3 mM ATP, had a statistically similar effect as 
0.3 mM ATP alone, against the HA that its light-stimulation had a significant long-term 
impact on Kir6.2Δ36 currents, giving a p-value = 0.001.  * indicates p<0.05.  
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Figure 11 
Activation of Kir6.2Δ36 Currents by Perfusion of 3 mM NaHS without DiC8:  
Representative time course of whole-cell patch-clamp inward currents with HEK-293 
cells transfected with Kir6.2Δ36, with 0.3 mM ATP in the patch pipette.  Perfusion by the 
High-K+ solution began at t = 10 sec; perfusion by the NaHS solution began at t = 150 
sec (marked by vertical blue line); and perfusion by the barium solution began at t = 500 
sec. The voltage-ramp protocol used was identical to the one shown in Figures 3 and 5. 
Pipette resistance = 4.7-4.9 MΩ.  Series Resistance = 24.1 MΩ.  Whole Cell 
Capacitance = 14.0 pF.  Recording Resistance ≈ 1 GΩ. 
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Figure 12 
Activation of Kir6.2Δ36 Currents by Perfusion of 3 mM NaHS with 0.2 mM DiC8 in 
the Patch Pipette: Representative time course of whole-cell patch-clamp inward 
currents with HEK-293 cells transfected with Kir6.2Δ36, with 0.3 mM ATP and 0.2 mM 
DiC8 in the patch pipette.  Perfusion by the High-K+ solution began at t = 10 sec; 
perfusion by the NaHS solution began at t = 250 sec (marked by vertical blue line); and 
perfusion by the barium solution began at t = 500 sec.  The voltage-ramp protocol used 
was identical to the one shown in Figures 3 and 5. Pipette resistance = 4.6-4.8 MΩ.  
Series Resistance = 47.2 MΩ.  Whole Cell Capacitance = 13.0 pF.  Recording 
Resistance ≈ 1 GΩ.  
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Figure 13 
Average Percent Change of Kir6.2Δ36 Currents by Perfusion of 3 mM NaHS with 
and without 0.2 mM DiC8 in the Patch Pipette: Analysis of whole-cell patch-clamp 
inward currents comparing the average of currents over 11 sec before the start of 
perfusion of NaHS to the average of currents over 11 sec before the start of perfusion 
by the barium solution, which corresponds to the steady-state after changes in currents, 
gave a percent activation for each run.  These percent activations were averaged and 
are shown here.  Without the presence of DiC8 in the patch pipette, the currents showed 
an average percent activation of 370% +/- 120% (SEM), n = 6.  A 1-sample t-test was 
performed to test H0: μ = 0 against HA: μ > 0, and found that this average was 
statistically greater than 0%, p-value = 0.013.  Without the presence of DiC8, the 
currents showed an average percent activation of 530% +/- 120% (SEM), n = 6.  A 1-
sample t-test was performed to test H0: μ = 0 against HA: μ > 0, and found that this 
average was statistically greater than 0%, p-value = 0.003.  A one-tailed Mann-Whitney 
U test analysis was performed to test the H0 that there was no difference between 
activating effects of NaHS in the presence of 0.2mM DiC8 in the patch pipette to without 
it, to the HA that the presence of DiC8 increased these activating effects, giving a p-
value = 0.087. 
